跳至主要内容
临床试验/NL-OMON40837
NL-OMON40837撤回不适用

Intestinal microvascular alterations and cytokine kinetics following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy - MACH-study

Sint Antonius Ziekenhuis0 个研究点目标入组 15 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Patients > 18 years of age
  • In order to be eligible to participate in this study, a subject must meet all of the following criteria:
  • Undergoing a CS-HIPEC procedure for colorectal carcinoma
  • Chemotherapeutic agent used for HIPEC is Mitomycin-C
  • Signed informed consent

排除标准

  • A potential subject who meets any of the following criteria will be excluded from participation in this study:
  • * Age <18 years
  • * Atrial fibrillation (because of possible interference with FloTrac*/Vigileo* cardiac output monitor)
  • * Left ventricular ejection fraction *30%
  • * Serious pulmonary disease (resting pO2 <90% at room air)
  • * Renal failure (clearance <30 ml/min as calculated using the Modification of Diet in Renal Disease formula)
  • * Inadequate bone marrow function (ANC *1.5 x 109/L and/or platelet count * 100 x 109/L)
  • * Pre-existing liver failure (Serum bilirubin * 2 x ULN, and/or ALAT and ASAT * 3 x ULN or need for partial hepatectomy during CS
  • * History of auto-immune or chronic inflammatory disease and/or on immunomodulatory medication

研究者

相似试验

Intestinal microvascular alterations and cytokine... | 临床试验